Symptoms include:
Skin discoloration
"Foul, sweet" smelling discharge from lesions formed on skin
Distinctive black, bubble lesions on skin
Necrosis
Fever
Pain following site of surgery or trauma
Lightheadedness
Rapid heart rate
Numbness on affected site
Blisters
Air in subcutaneous tissues
Swelling
Jaundice

Etiology
Clostridium species produce more toxins and exhibit higher degrees of virulence than any other bacterial taxon. Clostridium infections are usually opportunistic, and occur in individuals with serious preexisting medical conditions. However, Clostridium infections are also known to occur in healthy individuals. Four species of Clostridium (Clostridium botulinum, Clostridium perfringens, Clostridium tetani, and Clostridium sordelli) are responsible for most human infections. Since Clostridium is an obligate anaerobe taxon, the bacterium infects hypoxic tissues, which had become anaerobic due to restricted blood flow, degradation of blood vessels, or atherosclerosis. Immunocompromised individuals exhibit higher susceptibility for infection and higher mortality rates. Virulence factors
Members of the Clostridium species exhibit a plethora of virulence factors. Common virulence factors associated with gas gangrene include alpha toxin and theta toxin. Clostridium perfingens causes 80–90% of infections and produces both these toxins. Alpha toxin (α-toxin)Clostridium perfingens alpha toxin is widely associated with gas gangrene as it is its main virulence factor whilst invading its host. Alpha toxin is associated with hemolysis, thus restricting blood flow towards the area of infection. As the surrounding circulatory system collapses, neutrophils and monocytes, eosinophils and basophils cannot reach target areas of infection. The hemolytic activity of alpha toxin produces an anaerobic environment essential for the proliferation of the bacteria. Alpha toxin also exhibits the ability to infiltrate surrounding cellular tissue and cause a cascade of aberrant biochemical activity.
The technique can accurately determine the time that it takes to develop the observed tumor and the type of index gestation, which includes term pregnancy, molar gestation, or non-molar abortion. Treatment
Due to the susceptability of choriocarcinomas to chemotherapy, it is the first line treatment for this disease. Treatment course depends on the FIGO Scoring System for GTN, which has various prognostic factors, and categorizes based on low risk with a score of 0-6 and high risk with a score of 7 and above. Low risk
Individuals with low risk GTN are usually treated with single agent chemotherapy, such as methotrexate and folinic acid (MTX/FA) or actinomycin D (ActD). Other treatment options for those with low risk include hysterectomy and surgical removal of the tumor if possible. High risk
Those with high risk GTN receive a multi-agent chemotherapy regimen, usually consisting of a weekly rotation of etopside, methotrexate, and actinomycin D given one week and cyclophosphamide and vincristine given the following week, with variations to treatment occurring on a patient-specific basis. In individuals who relapse, secondary chemotherapy is needed where treatment may vary from the original regimen. The treatment includes a platinum-etopside combination given with other chemotherapy medications, such as methotrexate and actinomycin D (EMA-EP), bleomycin (BEP), or ifosfamide (VIP, ICE). Additional treatment also consists of surgery and radiotherapy if deemed appropriate for the individual. This condition can also result in resistance to the medications used to treat it and failure of their success in the individuals.